Walden Biosciences is currently enrolling a Phase 2 clinical research study for people living with rare chronic kidney diseases READ MORE

Transforming the Treatment of Kidney Disease

Walden Biosciences is a completely different type of biotech company. Our science is changing the treatment of kidney disease for patients.

Read More

PIPELINE

Walden is advancing a pipeline of novel, disease-modifying therapies that directly target the kidney.

READ MORE

PATIENTS

At Walden, we are committed to developing promising new therapies for people living with kidney disease.

READ MORE